UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely CytoSorbents is implementing good security practices.
Cytosorbents Corporation is a publicly traded company (NasdaqCM: CTSO) located in Monmouth Junction, New Jersey. Cytosorbents has created a blood purification technology based on biocompatible, porous polymer beads that act like sponges in an attempt to remove harmful substances from the blood.CytoSorb, the company's first product to market, received its CE mark approval in 2011.CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency (DARPA) for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins.
This report shows a preliminary security rating for CytoSorbents. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Privilege escalation is the exploitation of a programming error, vulnerability, design flaw, ...
Outsourcing, digitization, and globalization have brought us new products and services, allowed for ...
Compare CytoSorbents's security performance with other companies